Ramipril brand name
Searched over 200M research papers
Summary
3 papers analyzed
These studies suggest Ramipril is available under various brand names.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta17 papers analyzed
Ramipril Brand Name: An Overview
Introduction to Ramipril
Ramipril is a second-generation angiotensin-converting enzyme (ACE) inhibitor prodrug, widely used for treating mild to moderate essential hypertension and post-myocardial infarction heart failure. It is known for its long elimination half-life, which allows for once-daily administration.
Common Brand Names of Ramipril
In the pharmaceutical market, Ramipril is available under various brand names. Two notable brand names are Ramace and Tritace. These brands are well-recognized and prescribed for their efficacy in managing hypertension and heart failure.
Evaluation of Commercial Brands in India
A study conducted to evaluate different commercial brands of Ramipril tablets marketed in India highlighted the importance of quality assessments. The study compared various brands manufactured by Indian pharmaceutical companies to ensure safety and efficacy. The evaluation included tests for diameter, thickness, hardness, weight variation, friability, disintegration, and dissolution, all of which met acceptable standards.
Impact of Generic Switch on Refill Compliance
A retrospective study investigated whether switching from brand name Ramipril to generic products after patent expiry affected patients' refill compliance. The study found that the switch did not negatively impact compliance. In fact, the probability of noncompliance was slightly lower in the generic group compared to the brand name group. This suggests that generic versions of Ramipril are just as effective in maintaining patient adherence to treatment regimens.
Conclusion
Ramipril, available under brand names such as Ramace and Tritace, is a crucial medication for managing hypertension and heart failure. Studies have shown that various commercial brands in India meet quality standards, and switching to generic versions does not adversely affect patient compliance. This ensures that patients have access to safe and effective treatment options.
Sources and full results
Most relevant research papers on this topic
